Valeant Pharmaceuticals International Inc.: Valeant Will Release Fourth-Quarter And Full-Year 2017 Financial Results On February 28

Tickers: VRX
LAVAL, Quebec, Feb. 6, 2018 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ('Valeant') will release its fourth-quarter and full-year 2017 financial results on Wednesday, Feb. 28, 2018. Valeant will host a conference call and live web cast at 8:00 a.m. EST to discuss the results and provide a business update. All materials will be made available on the investor relations section of the Valeant web site prior to the start of the call.

About Valeant

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
International Business Machines Corporation
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at

View original content with multimedia:

SOURCE Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals International Inc. published this content on 06 February 2018 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 06 February 2018 15:30:06 UTC.